Elevance Health, Inc.
ELV
$428.79
$1.920.45%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 422.25% | -58.86% | -55.83% | 2.40% | 162.38% |
| Total Depreciation and Amortization | 211.01% | -202.13% | -1.79% | 1.21% | 226.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 367.39% | -202.22% | 138.63% | -159.90% | 270.48% |
| Change in Net Operating Assets | -9,816.67% | -101.45% | 163.53% | -97.87% | 77.32% |
| Cash from Operations | 44.05% | -73.63% | 498.88% | -77.40% | 166.58% |
| Capital Expenditure | 39.13% | 3.01% | -2.79% | -15.77% | 14.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 99.64% | -6,322.22% |
| Divestitures | 111.11% | -- | -100.00% | -- | -- |
| Other Investing Activities | -87.73% | 3,585.51% | 92.25% | 2.31% | -26.35% |
| Cash from Investing | 106.29% | -308.48% | 50.98% | 64.59% | -124.49% |
| Total Debt Issued | -83.40% | 10,393.75% | -96.41% | -14.34% | 360.77% |
| Total Debt Repaid | 5.93% | -155.46% | -630.84% | 118.26% | -217.43% |
| Issuance of Common Stock | 43.75% | -66.67% | -20.00% | -38.14% | 142.50% |
| Repurchase of Common Stock | 44.71% | -2,648.48% | 85.75% | 30.48% | 28.23% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.49% | 1.32% | 0.00% | 0.26% | -9.54% |
| Other Financing Activities | -100.00% | -800.00% | -75.00% | 0.00% | 100.00% |
| Cash from Financing | -235.58% | 253.88% | -236.98% | 1,987.50% | 108.12% |
| Foreign Exchange rate Adjustments | 112.50% | -214.29% | 240.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -4,700.00% | 104.76% | -- | -- |
| Net Change in Cash | -286.73% | -69.17% | 405.17% | 190.33% | 93.17% |